MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease

Wen-Juan Tang1, Kai-Yue Peng1, Zi-Fei Tang1

  • 1Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai 201102, China.

Abstract

Insights

MicroRNA (miR)-15a regulates cell division cycle (Cdc)42, impacting epithelial junctions in pediatric inflammatory bowel disease (IBD). This study reveals miR-15a

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Pediatric Inflammatory Bowel Disease (IBD) Research

Background:

  • Pediatric inflammatory bowel disease (IBD) involves complex molecular dysregulation.
  • MicroRNAs (miRNAs) play critical roles in cellular processes and disease pathogenesis.
  • The specific role of miR-15a in IBD development requires further elucidation.

Purpose of the Study:

  • To investigate the regulatory relationship between miR-15a and cell division cycle (Cdc)42.
  • To determine the impact of miR-15a and Cdc42 on epithelial junction integrity in IBD.
  • To examine the expression patterns of miR-15a and Cdc42 in pediatric IBD patients.

Main Methods:

  • Dual-luciferase assays and TargetScan to identify miR-15a targets.
  • In vitro studies using Caco-2 cells with manipulated miR-15a and Cdc42 expression.
  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunofluorescence for gene and protein expression analysis.
  • Endoscopic tissue collection from pediatric IBD patients for expression profiling.

Main Results:

  • Cdc42 was confirmed as a direct target of miR-15a.
  • Tumor necrosis factor-α (TNF-α) stimulation increased miR-15a and decreased Cdc42, ZO-1, and E-cadherin expression.
  • miR-15a mimicry reduced Cdc42, ZO-1, and E-cadherin, while miR-15a inhibition partially restored them.
  • In pediatric IBD patients, miR-15a was upregulated and Cdc42 downregulated, correlating with disease activity.

Conclusions:

  • miR-15a negatively regulates epithelial junction proteins, including ZO-1 and E-cadherin, via Cdc42.
  • The miR-15a/Cdc42 axis is implicated in the pathogenesis of pediatric IBD.
  • Targeting the miR-15a/Cdc42 pathway may offer therapeutic potential for pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
986
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
517
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
605
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
738
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K